Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel marker of ameloblastoma and systematic review of immunohistochemical findings.

Annals of diagnostic pathology - 1 Jun 2016

Khalele Bacem A E O, Al-Shiaty Rami A

Abstract excerpt

This study aims at investigating the pathogenesis and oncogenesis of ameloblastoma. Being the commonest odontogenic tumor with idiopathic nature, ameloblastoma poses a fierce controversy about its oncogenesis. Immunohistochemical markers, over years, have highlighted specific pathways which are inherently undertaken in the tumorigenic process of ameloblastoma. Besides the recently pronounced clue of BRAF V600E...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ameloblastoma
Share to Biomarkers, Tumor
Share to Carcinogenesis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to BRAF gene

Share to Immunohistochemistry

Share to Odontogenic Tumors

Share to Phenotype

Source

Identifiers

PMID: 27180055
DOI: 10.1016/j.anndiagpath.2016.01.005

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel marker of ameloblastoma and systematic review of immunohistochemical findings.PMID 27180055Read ↗

Molecular biology exploration and targeted therapy strategy of Ameloblastoma.Semantic proximity Read ↗

Ameloblastoma: A succinct review of the classification, genetic understanding and novel molecular targeted therapies.Semantic proximity Read ↗

Genes and Genetic Pathways Regarding the Etiology and Pathogenesis of Ameloblastoma.Semantic proximity Read ↗

Molecular pathogenesis of ameloblastoma.Semantic proximity Read ↗

BRAF V600E mutation-specific immunohistochemical analysis in ameloblastomas: a 44-patient cohort study from a single institution.Semantic proximity Read ↗

Effectiveness of molecular-targeted chemotherapy in ameloblastomas: A systematic review.Semantic proximity Read ↗

Differential Expression of Immunohistochemical Markers in Ameloblastoma & Ameloblastic Carcinoma: A Systematic Review and Meta-analysis of observational studiesSemantic proximity Read ↗

BRAF p.V600E status in epithelial areas of ameloblastoma with different histological aspects: Implications to the clinical practice.Semantic proximity Read ↗

Cystic Plexiform Ameloblastoma – an important diagnostic challengeSemantic proximity Read ↗

BRAF p.V600E Mutational Status Does Not Correlate with Biological Behavior in Conventional Ameloblastomas: A Disease-Free Survival Analysis.Semantic proximity Read ↗

Immunohistochemical analysis of BRAF V600E mutation in ameloblastomas.Semantic proximity Read ↗

Progress towards personalized medicine for ameloblastoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.